7,242
Views
10
CrossRef citations to date
0
Altmetric
Review

Nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex - disease burden, unmet needs, and advances in treatment developments

, , , , , & show all
Pages 1387-1401 | Received 24 May 2021, Accepted 27 Sep 2021, Published online: 18 Oct 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Tatsunori Murata, Kozo Morimoto, Fujio Matsuyama, Mayumi Yamada, Joseph Feliciano & Mariam Hassan. (2023) Health state utility estimation of Mycobacterium avium complex pulmonary disease using a time trade-off approach. Journal of Medical Economics 26:1, pages 477-487.
Read now
Kamal A. Hamed & Glenn Tillotson. (2023) A narrative review of nontuberculous mycobacterial pulmonary disease: microbiology, epidemiology, diagnosis, and management challenges. Expert Review of Respiratory Medicine 0:0, pages 1-16.
Read now

Articles from other publishers (7)

Akira Aoki, Hideto Jinno, Kenji Ogawa, Taku Nakagawa, Takayuki Inagaki, Takeaki Wajima, Yoshinori Okamoto & Kei-ichi Uchiya. (2023) A Rapid Screening Assay for Clarithromycin-Resistant Mycobacterium avium Complex Using Melting Curve Analysis with Nonfluorescent Labeled Probes. Microbiology Spectrum 11:1.
Crossref
Roald van der Laan, Andy Snabilié & Marko Obradovic. (2022) Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and delivery. Respiratory Research 23:1.
Crossref
Timothy Aksamit, Jasmanda Wu, Mariam Hassan, Emily Achter & Anjan Chatterjee. (2022) Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settings. BMC Pulmonary Medicine 22:1.
Crossref
Rebecca Vande Voorde, Elizaveta Dzalamidze, Dylan Nelson & Lia Danelishvili. (2022) Identification of Small Molecule Inhibitors against Mycobacteria in Activated Macrophages. Molecules 27:18, pages 5824.
Crossref
Ken K. P. Chan & David S. C. Hui. (2022) Contemporary Concise Review 2021: COVID ‐19 and other respiratory infections . Respirology 27:8, pages 661-668.
Crossref
Valérie Forest & Jérémie Pourchez. (2022) Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?. Advanced Drug Delivery Reviews 183, pages 114173.
Crossref
А.С. Зайцева, И.Э. Степанян & Е.И. Шмелев. (2022) МИКОБАКТЕРИОЗ ЛЕГКИХ: НЕРЕШЕННЫЕ ВОПРОСЫ АНТИБАКТЕРИАЛЬНОЙ ТЕРАПИИ, "Вестник Центрального научно-исследовательского института туберкулеза". Вестник ЦНИИТ:1, pages 6-16.
Crossref